Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status

30Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

The thymidine analogue 4-thiothymidine (S4TdR) is a photosensitizer for UVA radiation. The UV absorbance spectrum of S 4TdR and its incorporation into DNA suggests that it might act synergistically with nonlethal doses of UVA to selectively kill hyperproliferative or cancerous skin cells. We show here that nontoxic concentrations of S4TdR combine with nonlethal doses of UVA to kill proliferating cultured skin cells. Established cell lines with a high fraction of proliferating cells were more sensitive than primary keratinocytes or fibroblasts to apoptosis induction by S4TdR/UVA. Although S 4TdR plus UVA treatment induces stabilization of p53, cell death, as measured by apoptosis or clonal survival, occurs to a similar extent in both p53 wild-type and p53-null backgrounds. Furthermore, different types of human papilloma virus E6 proteins, which protect against UVB-induced apoptosis, have little effect on killing by S4TdR/UVA. S4TdR/UVA offers a possible therapeutic intervention strategy that seems to be applicable to human papilloma virus-associated skin lesions. Copyright © 2007 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Reelfs, O., Xu, Y. Z., Massey, A., Karran, P., & Storey, A. (2007). Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status. Molecular Cancer Therapeutics, 6(9), 2487–2495. https://doi.org/10.1158/1535-7163.MCT-07-0166

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free